1. Home
  2. CYD vs ORKA Comparison

CYD vs ORKA Comparison

Compare CYD & ORKA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CYD
  • ORKA
  • Stock Information
  • Founded
  • CYD 1951
  • ORKA 2004
  • Country
  • CYD Singapore
  • ORKA United States
  • Employees
  • CYD N/A
  • ORKA N/A
  • Industry
  • CYD Industrial Machinery/Components
  • ORKA Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • CYD Industrials
  • ORKA Health Care
  • Exchange
  • CYD Nasdaq
  • ORKA Nasdaq
  • Market Cap
  • CYD 609.7M
  • ORKA 580.3M
  • IPO Year
  • CYD 1994
  • ORKA N/A
  • Fundamental
  • Price
  • CYD $30.63
  • ORKA $15.00
  • Analyst Decision
  • CYD
  • ORKA Strong Buy
  • Analyst Count
  • CYD 0
  • ORKA 9
  • Target Price
  • CYD N/A
  • ORKA $40.38
  • AVG Volume (30 Days)
  • CYD 278.4K
  • ORKA 139.2K
  • Earning Date
  • CYD 08-08-2025
  • ORKA 08-11-2025
  • Dividend Yield
  • CYD 1.71%
  • ORKA N/A
  • EPS Growth
  • CYD 40.10
  • ORKA N/A
  • EPS
  • CYD 1.66
  • ORKA N/A
  • Revenue
  • CYD $3,159,401,156.00
  • ORKA N/A
  • Revenue This Year
  • CYD $6.43
  • ORKA N/A
  • Revenue Next Year
  • CYD $11.20
  • ORKA N/A
  • P/E Ratio
  • CYD $18.39
  • ORKA N/A
  • Revenue Growth
  • CYD 17.99
  • ORKA N/A
  • 52 Week Low
  • CYD $8.61
  • ORKA $5.49
  • 52 Week High
  • CYD $32.24
  • ORKA $52.32
  • Technical
  • Relative Strength Index (RSI)
  • CYD 69.47
  • ORKA 56.34
  • Support Level
  • CYD $29.30
  • ORKA $14.10
  • Resistance Level
  • CYD $31.10
  • ORKA $15.76
  • Average True Range (ATR)
  • CYD 1.62
  • ORKA 1.06
  • MACD
  • CYD 0.35
  • ORKA 0.01
  • Stochastic Oscillator
  • CYD 82.85
  • ORKA 69.52

About CYD China Yuchai International Limited

China Yuchai International Ltd is a Bermuda holding company that is a subsidiary of Singapore-based Hong Leong Asia. China Yuchai International primarily operates through its majority-owned subsidiary Guangxi Yuchai Machinery Company, a China-based company that manufactures, assembles, and distributes diesel engines for various vehicles including trucks, buses, and cars, as well as construction and agricultural, marine, and power-generation equipment. It generates the majority of its sales from the Chinese market.

About ORKA Oruka Therapeutics Inc. Common Stock

Oruka Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel monoclonal antibody therapeutics for psoriasis (PsO) and other inflammatory and immunology (I&I) indications. Its lead program, ORKA-001, is designed to target the p19 subunit of interleukin-23 (IL-23p19) for the treatment of PsO. The company's co-lead program, ORKA-002, is designed to target interleukin-17A and interleukin-17F (IL-17A/F) for the treatment of PsO, psoriatic arthritis (PsA), and other conditions. These programs each bind their respective targets at high affinity and incorporate half-life extension technology to increase exposure and decreasing dosing frequency.

Share on Social Networks: